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ABSTRACT
Objectives: Bacterial carriage in the upper respiratory
tract is usually asymptomatic but can lead to respiratory
tract infection (RTI), meningitis and septicaemia. We
aimed to provide a baseline measure of Streptococcus
pneumoniae, Moraxella catarrhalis, Pseudomonas
aeruginosa, Staphylococcus aureus, Haemophilus
influenzae and Neisseria meningitidis carriage within the
community. Self-swabbing and healthcare professional
(HCP) swabbing were compared.
Design: Cross-sectional study.
Setting: Individuals registered at 20 general
practitioner practices within the Wessex Primary Care
Research Network South West, UK.
Participants: 10 448 individuals were invited to
participate; 5394 within a self-swabbing group and
5054 within a HCP swabbing group. Self-swabbing
invitees included 2405 individuals aged 0–4 years and
3349 individuals aged ≥5 years. HCP swabbing invitees
included 1908 individuals aged 0–4 years and 3146
individuals aged ≥5 years.
Results: 1574 (15.1%) individuals participated, 1260
(23.4%, 95% CI 22.3% to 24.5%) undertaking self-
swabbing and 314 (6.2%, 95% CI 5.5% to 6.9%)
undertaking HCP-led swabbing. Participation was lower in
young children and more deprived practice locations.
Swab positivity rates were 34.8% (95% CI 32.2% to
37.4%) for self-taken nose swabs (NS), 19% (95% CI
16.8% to 21.2%) for self-taken whole mouth swabs
(WMS), 25.2% (95% CI 20.4% to 30%) for
nasopharyngeal swabs (NPS) and 33.4% (95% CI 28.2%
to 38.6%) for HCP-taken WMS. Carriage rates of S. aureus
were highest in NS (21.3%). S. pneumoniae carriage was
highest in NS (11%) and NPS (7.4%).M. catarrhalis
carriage was highest in HCP-taken WMS (28.8%). H.
influenzae and P. aeruginosa carriage were similar between
swab types. N. meningitidis was not detected in any swab.
Age and recent RTI affected carriage of S. pneumoniae
and H. influenzae. Participant costs were lower for self-
swabbing (£41.21) versus HCP swabbing (£69.66).
Conclusions: Higher participation and lower costs of self-
swabbing as well as sensitivity of self-swabbing favour this
method for use in large population-based respiratory
carriage studies.
INTRODUCTION
The respiratory tract is host to a wide variety
of commensal and pathogenic microorgan-
isms, with approximately 250 species colonis-
ing the nasopharynx alone.1 Asymptomatic
carriage in the upper respiratory tract (URT)
is the ﬁrst stage in the process of respiratory
tract infection (RTI), meningitis and sepsis.
Carriage often occurs without disease but
may also lead to serious invasive illness.2 3 In
2010, approximately 4.4 million deaths
worldwide resulted from an RTI, most com-
monly in young children.4
Collecting samples from the URT enables
the estimation of carriage rates of pathogenic
organisms. The determination of carriage
rates is essential for assessing circulating
respiratory microbes which may go on to cause
disease. A number of sites within the URT
have been used to assess carriage, including
the nasopharynx, oropharynx, nose and
throat. Methods for assessing carriage have
included swabbing, nose blowing and nasopha-
ryngeal aspiration.5–12 However, no single
study has evaluated the use of different swab-
bing methods using a large population-based
sample. Streptococcus pneumoniae remains the
Strengths and limitations of this study
▪ This study is the largest community-based swab-
bing study to date to compare carriage rates of
multiple bacterial species simultaneously
between self-swabbing and healthcare profes-
sional swabbing methods.
▪ This study provides important evidence for the
use of nose swabs for detection of
Streptococcus pneumoniae and other respiratory
pathogens.
▪ Non-response bias needs to be considered
within both self-swabbing and healthcare profes-
sional swabbing groups.
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only bacterial species for which a WHO standard method
has been established for detecting carriage.13 It is cur-
rently recommended to take a nasopharyngeal swab
despite other sites being equally as effective, if not more
sensitive, in assessing carriage of this organism.7 10
Self-swabbing has also been shown to be effective in asses-
sing nasal carriage of Staphylococcus aureus and viruses and
offers a cheaper alternative to more traditional healthcare
professional (HCP) swabbing.12 14
Most carriage studies have focused on a particular
organism and participant age group. However, many
microorganisms are thought to play a role in RTI devel-
opment and carriage in all age groups is important in
terms of understanding disease transmission and
immunity against speciﬁc pathogens.15 Moreover, in the
current vaccine era, we are likely to see an explosion of
new vaccines during the coming decade that will affect
the respiratory tract microbiota.16–20 This highlights the
need for large population-based studies that include all
age groups and aim to detect as many relevant microbial
species as possible.
Our study aimed to provide a baseline measure for
understanding multispecies bacterial carriage in the
respiratory tract within the general population of one
geographical area of the UK. The objectives were to
assess the optimal sample collection method and site by
comparing self-taken nose and mouth swabs with
HCP-taken nasopharyngeal and mouth swabs; to gain an
estimate of participant consent rates in both study
groups and to test the feasibility of conducting a larger
multisite investigation. Finally, the study aimed to esti-
mate carriage rates of relevant URT bacterial species.
This would help inform samples sizes for multicentre
studies, particularly for use in prevaccine and postvac-
cine studies, as well as to aid in understanding the
effects of demographic factors and deprivation on
carriage.
METHODS
Sample size
This was a pilot study and not designed to have the
power to detect non-inferiority of estimating carriage
rates by HCP-administered versus self-administered
swabs. Data from this study was predicted to inform
sample sizes required for future large carriage studies.
The sample size for this pilot study was based on the pre-
cision with which we can estimate true carriage rates. A
25% response rate among self-swabbing participants was
assumed based on results from a previous staphylococcal
carriage study.12 A 25% response rate was also assumed
for HCP-swabbing.
We estimated that by inviting 2020 children (101 from
each general practitioner (GP) practice) aged 0–4 years
and 3200 older children and adults (160 from each GP
practice) to participate within each swabbing group, this
would result in 505 children and 800 older children and
adult responders within each swabbing group,
accounting for predicted lower carriage rates in older
children and adults. A predicted carriage rate of 30% in
505 participating children would enable the determin-
ation of true carriage to within ±4% (95% conﬁ-
dence).21 A predicted carriage rate of 20% in 800
participating older children and adults would enable the
determination of true carriage to within ±2.8% (95%
conﬁdence).9
Participant recruitment
Participants were selected from 20 GP practices within
the Wessex Primary Care Research Network (PCRN)
South West (East hub) area, in Southern England. GP
practices were chosen to reﬂect a mix of urban/rural
locations, practice sizes and area deprivation levels. Each
GP practice produced a list of their entire patient
cohort. Any individual deemed unﬁt for participation at
the discretion of their GP, for example due to terminal
illness or serious mental health problems, was removed
from the list. From each GP list, 202 individuals aged 0–
4 years and 320 individuals aged ≥5 years were randomly
selected and allocated to one of two study groups using
the ralloc command in Stata V.12. This resulted in
approximately 101 individuals aged 0–4 years and 160
individuals aged ≥5 years within each swabbing group
per GP practice.
The HCP group involved participants being invited,
via letter, to organise a swabbing appointment at their
GP practice where nasopharyngeal (NPS) and whole
mouth (WMS) swabs were taken by a registered HCP.
Appointments were within normal surgery opening
hours and at the individuals’ GP practice (local to each
participant). The self-swabbing group involved partici-
pants being sent a self-swabbing pack containing nose
(NS) and WMS swabs by Danvers International
(London, UK). Participants were not sent reminders. All
swab heads were viscose (rayon). Nose and both WMS
shafts were polystyrene whereas NP swab shafts were alu-
minium. Once taken, swabs were placed in polypropyl-
ene tubes containing amies transport medium with
charcoal. HCP-taken swabs were returned for analysis on
the day of swabbing by taxi or within 1–2 days by pre-
existing National Health Service (NHS) delivery service.
Self-taken swabs were returned by ﬁrst-class freepost
return (1–2 days).
Each participant was given an age-appropriate infor-
mation sheet explaining the study aims, which aimed to
motivate individuals to participate. Participants were
asked to complete a consent form and questionnaire,
provided either at their swabbing appointment or within
their self-swabbing pack. The study questionnaire was
identical for both study groups and requested the follow-
ing details pertinent to bacterial carriage: participant
age, recent use of antibiotics (within the past month),
recent RTI (cold, ﬂu, ear infection or chest infection
within the past month) and vaccination status. Age was
split into the following groups for analysis: 0–4, 5–17,
18–64 and 65 years and older due to the relevance of
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each of these age groups in carriage of the different bac-
terial species. Recent use of antibiotics and recent RTI
were split into the following groups for analysis: yes, no
and do not know/missing. Vaccination status was split
into the following groups for analysis: up-to-date, not
up-to-date and do not know/missing. UK Index of
Multiple Deprivation (IMD) 2010 scores were obtained
for each GP practice based on the lower layer super
output area (LSOA) it was located in and was used as a
proxy for deprivation of each practices’ patient popula-
tion.22 UK IMD 2010 Score includes seven features of
deprivation: income, education, employment, health,
housing, crime and living environment. More deprived
areas have lower levels of these seven features whereas
less deprived areas have higher levels for the same seven
features. This would enable the relationship between
carriage and deprivation to be assessed, as in disease
studies.23 A total of 10 448 individuals were invited to
participate in the study.
Sample collection and analysis
Self-swabbing packs were sent out to individuals between
the 15 May and 23 July 2012 and samples were received
between the 18 May and 31 August 2012. HCP swabbing
appointments took place between 7 June and 28 August
and samples were received between the 7 June and 31
August. On receipt, swabs were immersed in skim milk,
tryptone, glucose and glycerine (STGG) storage media,
vigorously rubbed against the side of the tube and vor-
texed to ensure transfer of bacteria into the STGG.
Standard microbiology culture and identiﬁcation techni-
ques were used to analyse the swab contents for the pres-
ence of S. pneumoniae, Haemophilus inﬂuenzae, Moraxella
catarrhalis, S. aureus, Pseudomonas aeruginosa and Neisseria
meningitidis. This was performed by transferring 10 μL
STGG onto Columbia blood agar with horse blood
(Oxoid, PB0124), Columbia blood agar with colistin and
nalidixic acid (Oxoid, PB0308), Columbia blood agar
with chocolated horse blood (Oxoid, PB0124),
Columbia blood agar with chocolated horse blood and
bacitracin (Oxoid, PB0220), Pseudomonas selective agar
(Oxoid, PB0291) and lysed GC selective agar (Oxoid,
PB0962). Identiﬁcation of each bacterial species was
undertaken according to methodology described in
online supplementary table S1. After plating, the
remaining swab content in STGG was then frozen for
future use at −70°C.
Statistical analysis
Culture data and participant questionnaire information
were tabulated into SPSS (V.20) for analysis. Missing or
incomplete data was classed as missing within the SPSS
variables window. Participation rates, the proportion of
participants relative to total number of individuals
invited, were calculated for each GP practice and age
group. UK IMD 2010 scores for each GP practice area
were examined in relation to participation rates using
Pearson’s Correlation. Swab positivity rates, the
proportion of swabs that isolated any of the target bac-
teria relative to total swab numbers, were calculated for
each swab type. 95% CIs were calculated to assess reli-
ability of participation and positivity rates.
Carriage rates, the proportion of a speciﬁc bacterial
species relative to total number of swabs, were calculated
according to swab type, age, recent RTI, recent anti-
biotic use, vaccination status, geographical location and
deprivation. χ2 and Fisher’s Exact tests were used to
determine any associations between carriage and these
variables. Geographical mapping of carriage rates was
performed using ArcGIS (ESRI, V.10.1).24 Practices were
grouped into geographical areas for statistical analysis
based on proximity to one another. Finally, co-carriage
rates, the proportion of samples containing multiple
bacterial species relative to total number of swabs, were
calculated according to swab type, age, recent RTI,
recent antibiotic use, vaccination status and geographical
location.
Study costs
Total costs associated with each swabbing method were
calculated to allow cost comparisons between methods.
Costs were calculated as total costs within a single swab-
bing group divided by the total number of responders
from that swabbing group. This included swab packs
sent out to individuals but not used. Costs were sepa-
rated into laboratory consumables, printing, swabs, NHS
Service Support Costs (additional healthcare costs due
to the research taking place), transport and postage.
RESULTS
Participation rates
Eighteen of the 20 GP practices participated in both self-
swabbing and HCP-swabbing, one participated in self-
swabbing only and one dropped out of the study.
Participant characteristics are shown in table 1. Overall
participation rates were higher in the self-swabbing
group at 23.4% (n=1260; N=5395; 95% CI 22.3% to
24.5%) compared with the HCP group at 6.2% (n=314;
N=5054; 95% CI 5.5% to 6.9%). Self-swabbing participa-
tion rates varied from 9.3% (n=27; N=290) to 33.1%
(n=96; N=290) between practices whereas HCP partici-
pation rates varied from 1% (n=3; N=290) to 12.3%
(n=34; N=277). Ten practices had participation rates
≥25% in the self-swabbing group, which was the antici-
pated level of participation. There was a negative correl-
ation between participation rate and IMD score in the
self-swabbing group (r=−0.473, p=0.041) and the HCP
group (r=−0.417, p=0.085), which was only signiﬁcant in
the former. Participation was higher in individuals aged
≥5 years at 27.8% (n=931; N=3349; 95% CI 26.8% to
29.3%) in the self-swabbing group and 8.2% (n=258;
N=3146; 95% CI 7.2% to 9.2%) in the HCP group versus
0–4 years at 16.1% (n=329; N=2045; 95% CI 14.5% to
17.7%) in the self-swabbing group and 2.9% (n=56;
N=1908; 95% CI 2.2% to 3.7%) in the HCP group. The
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greatest number of responses received was from indivi-
duals aged 50–80 years, comprising 41.7% (n=656,
N=1574) of total participants.
Swab positivity rates
Out of 1260 self-swabbing participants, 1254 returned
both swabs with labels distinguishing nose from WMS
but six individuals failed to label their swabs and thus
were excluded from analyses. Out of 314 HCP swabbing
participants, 309 had both swabs returned by their GP
but ﬁve individuals were incorrectly swabbed by their GP
and thus were excluded from analyses. Swab positivity
rates were 35% (n=439; N=1254; 95% CI 32.4% to
37.6%) for NS, 19.1% (n=239; N=1254; 95% CI 16.9% to
21.3%) for self-taken WMS, 25.6% (n=79; N=309; 95%
CI 20.7% to 30.5%) for NPS and 34% (n=105; N=309;
95% CI 28.7% to 39.3%) for HCP-taken WMS (see
online supplementary ﬁgure S1). The NS and
HCP-taken WMS were most effective in detecting car-
riage of the target organisms. Positivity rates of NS were
signiﬁcantly higher than NPS (χ2=9.974, df=1, p=0.002).
Positivity rates of HCP-taken WMS were signiﬁcantly
higher than self-taken WMS (χ2=32.157, df=1, p<0.001).
Bacterial carriage rates
Carriage rates within each swab type (ﬁgure 1) show few
signiﬁcant differences between self-swabbing and HCP
swabbing. S. pneumoniae carriage was similar between NS
and NPS (χ2=3.403, df=1, p=0.075) and between self-
taken and HCP-taken WMS (test value=0.139, df=1,
p=0.661). M. catarrhalis carriage was similar between NS
and NPS (χ2=3.757, df=1, p=0.058) but signiﬁcantly
higher in HCP-taken WMS compared to self-taken WMS
(χ2=43.404, df=1, p<0.001). S. aureus carriage was signiﬁ-
cantly higher in NS than NPS (χ2=13.161, df=1, p<0.001)
but was similarly low in self-taken and HCP-taken WMS
(χ2=1.218, df=1, p=0.315). H. inﬂuenzae carriage was simi-
larly low in NS and NPS (χ2=0.193, df=1, p=0.700) as
well as in self-taken and HCP-taken WMS (test
value=2.888, df=1, p=0.151). P. aeruginosa carriage was
similar in NS and NPS (test value=0.148, df=1, p=1.000)
as well as in self-taken and HCP-taken WMS (χ2=0.032,
df=1, p=1.000) N. meningitidis was not detected in any
swab type used in this study.
Cocarriage rates
Overall cocarriage rates were 3.9% (n=49; N=1219; 95% CI
2.8% to 5%) in NS, 1.1% (n=13; N=1219; 95% CI 0.5% to
1.7%) in self-taken WMS, 2.3% (n=7; N=307; 95% CI 0.6%
to 4%) in NPS and 1.6% (n=5; N=307; 95% CI 0.2% to
3%) in HCP-taken WMS. In NS and NPS, cocarriage rates
were signiﬁcantly higher in individuals aged 0–4 years (NS
(9.1%; n=30; N=329; 95% CI 6% to 12.2%) and NPS
(8.9%; n=5; N=56, 95% CI 1.4% to 16.4%)) versus
≥5 years (NS (2.1%; n=19; N=907; 95% CI 1.2% to 3%)
and NPS (1.8%; n=2; N=253, 95% CI 0.2% to 3.4%)).
Nose cocarriage decreased with age, with 8% (n=11;
N=137, 95% CI 3.5% to 12.5%) in individuals aged 5–
17 years, 1.1% (n=5; N=464; 95% CI 0.2% to 2.1%) in indi-
viduals aged 18–64 years and 1% (n=3; N=306; 95% CI
−0.1% to 2.1%) in those aged ≥65 years. The most
common cocarriage relationship in nose swabs was
between S. pneumoniae and H. inﬂuenzae (50% (n=15;
N=30) in 0–4 years, 26.3% (n=5, N=19) in ≥5 years).
Association between demographics and carriage
Participant age
Bacterial carriage was highly variable with age, in particu-
lar carriage of S. pneumoniae, H. inﬂuenzae M. catarrhalis
and S. aureus (tables 2 and 3). Carriage rates of S. pneumo-
niae and H. inﬂuenzae in both NS and NPS decreased with
age, with 0–4-year-olds experiencing the highest carriage
rates. S. pneumoniae carriage dropped off signiﬁcantly
after 5 years of age with >2× difference in NS and >3× dif-
ference in NPS between those aged 0–4 years and those
aged 5–17 years. S. pneumoniae carriage in self-taken WMS
Table 1 Participant characteristics and study costs (in
British Pounds) for self-swabbing and HCP swabbing
Participant
characteristics n(%) and
costs per participant (£)
Self-
swabbing
HCP
swabbing
Age (years)
Mean 37.42 50.09
Minimum 0 0
Maximum 94 88
0–4 329 (26.1) 56 (17.8)
5–17 137 (10.9) 24 (7.6)
18–64 465 (36.9) 89 (28.3)
65+ 311 (24.7) 145 (46.2)
Missing 18 (1.4) 0 (0.0)
Recent antibiotic treatment
Yes 101 (8.0) 26 (8.3)
No 1124 (89.2) 286 (91.1)
Unknown/missing 35 (2.8) 2 (0.6)
Recent respiratory infection
Yes 365 (29.0) 61 (19.4)
No 860 (68.3) 250 (79.6)
Unknown/missing 35 (2.8) 3 (1.0)
Vaccination status
Up-to-date 1022 (81.1) 270 (86.0)
Not up-to-date 40 (3.2) 10 (3.2)
Unknown/missing 198 (15.7) 34 (10.8)
Costs per participant (£)
Laboratory consumables 8.06 8.47
Printing 2.14 7.23
Swabs and swab packs 17.08 9.65
Service support costs (SSC) 2.81 39.52
Transport (by taxi or internal
mail)
0.00 4.78
Postage 11.12 0.00
Total 41.21 69.66
Costs (British Pounds) are per participant taking into account
wastage of swabs and swab packs.
HCP, healthcare professional.
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also showed higher carriage in the young (0–4 years and
5–17 years age groups) compared with adults. H. inﬂuen-
zae nasal carriage decreased more steadily with age.
M. catarrhalis nose carriage was also highest in those aged
0–4 years but remained at lower levels in the other age
groups. S. aureus nose carriage increased sharply after the
age of 5 years but remained high in older children and
adults. S. aureus nose carriage was >3× higher in partici-
pants aged 5–17 years when compared with participants
0–4 years. P. aeruginosa did not vary between the age
groups in any swab type.
Participant questionnaire information
Higher nasal and NP carriage rates of S. pneumoniae and
H. inﬂuenzae were observed in participants who had
experienced a recent RTI. S. pneumoniae nose carriage
was >3× higher in those with recent RTI versus those
without recent RTI, using χ2 (χ2=66.408, df=1, p<0.001).
H. inﬂuenzae nose carriage was also >2× higher in those
with recent RTI versus those without recent RTI, using
the χ2 test (χ2=12.533, df=1, p=0.001). Recent antibiotic
treatment was only signiﬁcant in P. aeruginosa NP car-
riage, where recent antibiotics use was associated with
increased carriage of this bacterium (test value=9.018,
df=1, p=0.037). Vaccination status was not associated
with signiﬁcant changes in carriage of any of the target
bacteria. Full results are shown in tables 2 and 3. In NS,
recent RTI was also associated with higher co-carriage
rates at 8% (n=29) when compared with no recent RTI
at 2.2% (n=19). Recent antibiotic use, vaccination status
and geographical location did not appear to affect
co-carriage rates.
Geographical location
Carriage rates of the target bacterial species showed
some differences according to practice location (see
Figure 1 Bacterial Carriage
Rates (%) of (A) Streptococcus
pneumoniae (B) Moraxella
catarrhalis (C) Staphylococcus
aureus (D) Haemophilus
influenzae (E) Pseudomonas
aeruginosa by Swab Method and
Site. Graphs are bar charts
representing carriage frequencies
as percentages. Error bars
represent 95% CIs.
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Table 2 Bacterial nose and nasopharyngeal carriage rates of Streptococcus pneumoniae, Moraxella catarrhalis, Staphylococcus aureus, Haemophilus influenzae and Pseudomonas
aeruginosa by participant age group, recent RTI, recent antibiotic treatment and vaccination status
Category
Participants (N)
Carriage of bacterial species within nose and nasopharyngeal swabs in different participant categories % (n) (95% CI)
S. pneumoniae H. influenzae M. catarrhalis S. aureus P. aeruginosa
SS HCP Nose NP Nose NP Nose NP Nose NP Nose NP
Age (years)
0–4 329 56 32.8 (108)
(27.7 to 37.9)
33.9 (19)
(21.5 to 46.3)
7.3 (24)
(4.5 to 10.1)
10.7 (6)
(2.6 to 18.8)
5.8 (19)
(3.3 to 8.3)
10.7 (6)
(2.6 to 18.8)
9.7 (32)
(6.5 to 12.9)
5.4 (3)
(−0.5 to 11.3)
2.7 (9)
(1.0 to 4.5)
1.8 (1)
(−1.7 to 5.3)
5–17 137 22 13.1 (18)
(7.5 to 18.8)
9.1 (2)
(−2.9 to 21.1)
5.1 (7)
(1.4 to 8.8)
0.0 (0)
NA
0.7 (1)
(−0.7 to 2.1)
4.5 (1)
(−4.1 to 13.2)
35.0 (48)
(27.0 to 43.0)
13.6 (3)
(−0.7 to 27.9)
0.7 (1)
(−0.7 to 2.1)
0.0 (0)
NA
18–64 464 88 1.1 (5)
(0.2 to 2.1)
0.0 (0)
NA
0.2 (1)
(−0.2 to 0.6)
1.1 (1)
(−1.1 to 3.3)
1.5 (7)
(0.4 to 2.6)
3.4 (3)
(−0.4 to 7.2)
24.8 (115)
(20.9 to 28.7)
11.4 (10)
(4.8 to 18.0)
1.3 (6)
(0.3 to 2.3)
1.1 (1)
(−1.1 to 3.3)
65+ 306 143 2.0 (6)
(0.4 to 3.6)
1.4 (2)
(−0.5 to 3.3)
0.7 (2)
(−0.2 to 1.6)
0.0 (0)
NA
1.3 (4)
(0.0 to 2.6)
2.8 (4)
(0.1 to 5.5)
23.2 (71)
(18.5 to 27.9)
15.4 (22)
(9.5 to 21.3)
1.0 (3)
(−0.1 to 2.1)
1.4 (2)
(−0.5 to 3.3)
p Value <0.001* <0.001 <0.001 <0.001 0.001 0.100 <0.001* 0.263 0.288 1.000
Recent respiratory tract infection
Yes 363 59 22.3 (81)
(18.0 to 26.6)
15.3 (9)
(6.1 to 24.5)
5.2 (19)
(2.9 to 7.5)
6.8 (4)
(0.4 to 13.2)
3.6 (13)
(1.7 to 5.5)
3.4 (2)
(−1.2 to 8.0)
19.3 (70)
(15.2 to 23.4)
6.8 (4)
(0.4 to 13.2)
2.2 (8)
(0.7 to 3.7)
3.4 (2)
(−1.2 to 8.0)
No 856 247 6.3 (54)
(4.7 to 7.9)
5.7 (14)
(2.8 to 8.6)
1.6 (14)
(0.8 to 2.4)
1.2 (3)
(−0.2 to 2.6)
2.1 (18)
(1.1 to 3.1)
4.9 (12)
(2.2 to 7.6)
22.3 (191)
(19.5 to 25.1)
13.8 (34)
(9.5 to 18.1)
1.3 (11)
(0.5 to 2.1)
0.8 (2)
(−0.3 to 1.9)
p Value <0.001* 0.023 0.001* 0.028 0.163* 1.000 0.253* 0.188* 0.310* 0.169
Recent use of antibiotics
Yes 101 26 5.9 (6)
(1.3 to 10.5)
3.8 (1)
(−3.6 to 11.2)
1.0 (1)
(−0.9 to 2.9)
0.0 (0)
NA
1.0 (1)
(−0.9 to 2.9)
3.8 (1)
(−3.6 to 11.2)
15.8 (16)
(8.7 to 22.9)
0.0 (0)
NA
1.0 (1)
(−0.9 to 2.9)
7.7 (2)
(−2.6 to 18.0)
No 1118 281 11.5 (129)
(9.6 to 13.4)
7.8 (22)
(4.7 to 10.9)
2.9 (32)
(1.9 to 3.9)
2.5 (7)
(0.7 to 4.3)
2.7 (30)
(1.8 to 3.7)
4.6 (13)
(2.2 to 7.1)
21.7 (243)
(19.3 to 24.1)
13.5 (38)
(9.5 to 17.5)
1.5 (17)
(0.8 to 2.2)
0.7 (2)
(−0.3 to 1.7)
p Value 0.097* 0.706 0.515 1.000 0.508 1.000 0.203* 0.056 1.000 0.037
Vaccinations up-to-date
Yes 1017 265 12.8 (130)
(10.8 to 14.9)
8.7 (23)
(5.3 to 12.1)
3.0 (31)
(2.0 to 4.1)
2.6 (7)
(0.7 to 4.5)
2.8 (28)
(1.8 to 3.8)
4.5 (12)
(2.0 to 7.0)
20.4 (207)
(17.9 to 22.9)
13.2 (35)
(9.1 to 17.3)
1.6 (16)
(0.8 to 2.4)
1.5 (4)
(0.0 to 3.0)
No 40 10 5.0 (2)
(−1.8 to 11.8)
0.0 (0)
NA
2.5 (1)
(−2.3 to 7.3)
0.0 (0)
NA
2.5 (1)
(−2.3 to 7.3)
10.0 (1)
(−8.6 to 28.6)
25.0 (10)
(11.6 to 38.4)
0.0 (0)
NA
2.5 (1)
(−2.3 to 7.3)
0.0 (0)
NA
p Value 0.219 1.000 1.000 1.000 1.000 0.389 0.548* 0.621 0.484 1.000
χ2 (indicated by *) and Fisher’s exact tests for independence were used to determine significant differences between bacterial carriage rates in different age groups, with/without recent RTI, with/
without recent antibiotic treatment and with/without an up-to-date vaccination status. p Values are 2-tailed. 95% CI are written as (upper CI to lower CI).
NP, nasopharyngeal swab; NA, not applicable.
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Table 3 Bacterial self-taken and HCP-taken whole mouth swab carriage rates of Streptococcus pneumoniae, Moraxella catarrhalis, Staphylococcus aureus, Haemophilus influenzae and
Pseudomonas aeruginosa by participant age group, recent RTI, recent antibiotic treatment and vaccination status
Category
Participants
(N)
Carriage of bacterial species within mouth swabs in different participant categories % (n) (95% CI)
S. pneumoniae H. influenzae M. catarrhalis S. aureus P. aeruginosa
SS HCP
Self-taken
WMS
HCP-taken
WMS
Self-taken
WMS
HCP-taken
WMS
Self-taken
WMS
HCP-taken
WMS
Self-taken
WMS
HCP-taken
WMS
Self-taken
WMS
HCP-taken
WMS
Age (years)
0–4 329 56 1.2 (4)
(0.0 to 2.4)
3.6 (2)
(−1.3 to 8.5)
1.2 (4)
(0.0 to 2.4)
5.4 (3)
(−0.5 to 11.3)
11.9 (39)
(8.4 to 15.4)
35.7 (20)
(23.2 to 48.3)
2.4 (8)
(0.8 to 4.1)
0.0 (0)
NA
4.9 (16)
(2.6 to 7.2)
3.6 (2)
(−1.3 to 8.5)
5–17 137 22 1.5 (2)
(−0.5 to 3.5)
0.0 (0)
NA
0.0 (0)
NA
0.0 (0)
NA
11.7 (16)
(6.3 to 17.1)
27.3 (6)
(8.7 to 45.9)
4.4 (6)
(1.0 to 7.8)
4.5 (1)
(−4.2 to 13.2)
3.6 (5)
(0.5 to 6.7)
0.0 (0)
NA
18–64 464 88 0.0 (0)
NA
0.0 (0)
NA
0.9 (4)
(0.0 to 1.8)
1.1 (1)
(−1.1 to 3.3)
15.3 (71)
(12.0 to 18.6)
22.7 (20)
(14.0 to 31.5)
3.0 (14)
(1.5 to 4.6)
2.3 (2)
(−0.8 to 5.4)
1.7 (8)
(0.5 to 2.9)
2.3 (2)
(−0.8 to 5.4)
65+ 306 143 0.0 (0)
NA
0.0 (0)
NA
0.0 (0)
NA
0.7 (1)
(−0.7 to 2.1)
13.1 (40)
(9.3 to 16.9)
30.1 (43)
(22.6 to 37.6)
1.6 (5)
(0.2 to 3.0)
1.4 (2)
(−0.5 to 3.3)
2.9 (9)
(1.0 to 4.8)
3.5 (5)
(0.5 to 6.5)
p Value 0.006 0.063 0.204 0.159 0.476* 0.390* 0.361 0.377 0.079 0.910
Recent respiratory tract infection
Yes 363 59 0.8 (3)
(−0.1 to 1.7)
1.7 (1)
(−1.6 to 5.0)
0.8 (3)
(−0.1 to 1.7)
1.7 (1)
(−1.6 to 5.0)
10.5 (38)
(7.4 to 13.7)
25.4 (15)
(14.3 to 36.5)
2.5 (9)
(0.9 to 4.1)
0.0 (0)
NA
3.9 (14)
(1.9 to 5.9)
5.1 (3)
(−0.5 to 10.7)
No 856 247 0.4 (3)
(0.0–0.8)
0.4 (1)
(−0.4 to 1.2)
0.6 (5)
(0.1 to 1.1)
1.6 (4)
(0.0 to 3.2)
14.7 (126)
(12.3 to 17.1)
29.6 (73)
(23.9 to 35.3)
2.7 (23)
(1.6 to 3.8)
1.6 (4)
(0.0 to 3.2)
2.8 (24)
(1.7 to 3.9)
2.4 (6)
(0.5 to 4.3)
p Value 0.370 0.349 0.701 1.000 0.054* 0.632* 0.850* 1.000 0.368* 0.382
Recent use of antibiotics
Yes 101 26 0.0 (0)
NA
0.0 (0)
NA
0.0 (0)
NA
0.0 (0)
NA
14.9 (15)
(8.0 to 21.8)
23.1 (6)
(6.9 to 39.3)
3.0 (3)
(−0.3 to 6.3)
3.8 (1)
(−3.6 to 11.2)
2.0 (2)
(−0.7 to 4.7)
3.8 (1)
(−3.6 to 11.2)
No 1118 281 0.5 (6)
(0.1 to 0.9)
0.7 (2)
(−0.3 to 1.7)
0.7 (8)
(0.2 to 1.2)
1.8 (5)
(0.3 to 3.4)
13.4 (150)
(11.4 to 15.4)
29.2 (82)
(23.9 to 34.5)
2.6 (29)
(1.7 to 3.5)
1.4 (4)
(0.0 to 2.8)
3.2 (36)
(2.2 to 4.2)
2.8 (8)
(0.9 to 4.7)
p Value 1.000 1.000 1.000 1.000 0.761* 0.652* 0.744 0.360 0.764 0.554
Vaccinations up-to-date
Yes 1017 265 0.6 (6)
(0.1 to 1.1)
0.8 (2)
(−0.3 to 1.9)
0.6 (6)
(0.1 to 1.1)
1.9 (5)
(0.3 to 3.5)
13.7 (139)
(11.6 to 15.8)
29.4 (78)
(23.9 to 34.9)
2.8 (28)
(1.8 to 3.8)
1.5 (4)
(0.0 to 3.0)
3.2 (33)
(2.1 to 4.3)
3.0 (8)
(1.0 to 5.1)
No 40 10 0.0 (0)
NA
0.0 (0)
NA
2.5 (1)
(−2.3 to 7.3)
0.0 (0)
NA
5.0 (2)
(−1.8 to 11.8)
50.0 (5)
(19.0 to 81.0)
2.5 (1)
(−2.3 to 7.3)
0.0 (0)
NA
2.5 (1)
(−2.3 to 7.3)
0.0 (0)
NA
p Value 1.000 1.000 0.237 1.000 0.153* 0.175 1.000 1.000 1.000 1.000
χ2 (indicated by *) and Fisher’s exact tests for independence were used to determine significant differences between bacterial carriage rates in different age groups, with/without recent RTI, with/
without recent antibiotic treatment and with/without an up-to-date vaccination status. p Values are 2-tailed. 95% CI are written as (upper CI to lower CI).
NA, not applicable; WMS, whole mouth swab.
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online supplementary ﬁgure S2). Overall bacterial car-
riage was signiﬁcantly different by geographical area in
NS (χ2=11.609, df=5, p=0.04) and self-taken WMS
(χ2=13.900, df=5, p=0.02) but not in either HCP swab.
However, individual bacteria carriage rates were not sig-
niﬁcantly different between geographical areas.
Deprivation
Participants attending practices in less deprived locations
had slightly higher bacterial carriage rates, except for
P. aeruginosa, suggesting a possible negative relationship
between deprivation score and bacterial carriage.
However, the differences observed were not statistically
signiﬁcant.
Study costs
Overall, total costs per participant were over a third
lower in the self-swabbing group at £41.21 ($67.92)
versus the HCP group at £69.66 ($114.82; table 1). NHS
service support costs made up a large proportion of the
difference between the two study groups, representing
56.7% (£39.52/person) of costs in the HCP group but
only 6.8% (£2.81/person) of costs in the self-swabbing
group.
DISCUSSION
Our study demonstrates that self-swabbing is as effective
in detecting bacterial pathogens in the respiratory tract
as HCP swabbing and that nose swabs could be used
more routinely to detect the presence of bacterial
pathogens S. pneumoniae, H. inﬂuenzae, S. aureus and
P. aeruginosa. WMS, on the other hand, are the most sen-
sitive swab for detection of M. catarrhalis. The swabs
used in this study were not sensitive for detection of
N. meningitidis.
Higher participation rates within the self-swabbing
group compared with the HCP group highlight the will-
ingness of individuals to participate in such studies when
the process is facilitated. The very low participation rate
of the HCP group would render this method invalid for
large-scale studies. While the responsiveness of the self-
swabbing group was higher, it was still less than the
anticipated 25%, meaning there will always be a
problem of non-response bias. However, similar carriage
rates were observed in our study when compared with
previous swabbing studies, demonstrating that our
sample size is large enough to overcome differences that
may result from non-response bias. Barriers to participa-
tion in the HCP group might include the amount of
time required for organising and attending swabbing
appointments and the slight discomfort experienced
during nasopharyngeal swabbing. Self-swabbing over-
came many of these barriers by offering a relatively
straightforward, rapid and easy alternative. High partici-
pation rates in elderly participants might be a result of
their increased availability for participation and their
increased chance of exposure to RTI allowing them to
relate to the study aims. Parents may also be reluctant to
swab their children if they are very young. The negative
correlation between participation rates and deprivation
highlights certain barriers associated with high levels of
deprivation, which have been observed in other
studies.25
Swab positivity rates and bacterial carriage rates indi-
cate that self-swabbing is as effective as HCP swabbing in
sampling microbial species within the airways of the
general population within our large population-based
study. Higher positivity rates in NS versus NPS and
higher carriage of S. aureus within NS versus NPS dem-
onstrate the potential for using a self-taken NS rather
than HCP-taken NPS to detect respiratory pathogens.
Higher positivity rates in HCP-taken WMS versus self-
taken WMS and higher carriage of M. catarrhalis within
HCP-taken WMS demonstrate the sensitivity of
HCP-swabbing. However, lower participation rates with
fewer children and more elderly participants within
HCP swabbing have most probably resulted in reduced
carriage rates within NPS. Self-swabbing allowed the
recruitment of a greater spread of age groups, which is
essential for obtaining a true estimate of carriage. Very
low participation in the HCP group is problematic for
assessing carriage within the general population as fewer
numbers of samples can be obtained and the cost of
obtaining them is high. In order to obtain the same
spread of ages as the self-swabbing group, a much larger
number of individuals would need to be invited. The
high costs of HCP swabbing are mainly due to the oper-
ation of swabbing clinics. In order to increase participa-
tion, healthcare providers could undertake verbal
encouragement or study advertisement in practice. WMS
were efﬁcient in isolating M. catarrhalis and P. aeruginosa,
however, large amounts of background ﬂora within this
site and low isolation levels for the other bacteria render
this swab less efﬁcient on the whole. The lack of isola-
tion of N. meningitidis may be due to the type of swabs
used, as oropharyngeal swabs are often preferred.26 Low
response rates from teenagers, the most frequent car-
riers of N. meningitidis, may also have caused the lack of
isolation of this species.27
Carriage rates of ﬁve out of the six target organisms
follow previously observed patterns with S. pneumoniae
and H. inﬂuenzae being carried predominantly in young
children and S. aureus being carried more in older chil-
dren and adults.12 28 29 M. catarrhalis and P. aeruginosa
carriage rates were constant across all age groups dem-
onstrating that carriage of these organisms is unaffected
by age. N. meningitidis carriage did not follow previously
observed patterns as no isolates were detected. However,
the number of participants in the study may not have
been large enough to detect any isolates with 95% conﬁ-
dence. Furthermore, swab types used and turn-around
times from swabbing to sample processing may not be
optimal for N. meningitidis recovery. The effect of recent
RTI on carriage of S. pneumoniae and H. inﬂuenzae is one
that might be expected as colds and ﬂu weaken host
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immunity allowing for carriage by these organisms.30
The lack of an apparent effect of vaccination status is
potentially due to herd immunity, as unvaccinated
people beneﬁt from protection from disease as a result
of a largely vaccinated population.31 However, further
details of vaccines received via access to individual par-
ticipant immunisation records in future studies might
enable improved assessment of the effects of immunisa-
tion on carriage of target and non-target bacteria.
This pilot study has also enabled all aspects of study
set-up through to completion to be tried and tested,
which will be essential for setting up larger swabbing
studies. Study documentation, study protocol, ethics
application and sample size calculations have been
trialled and alterations can now be performed on
further studies in order to improve outcomes and efﬁ-
ciency. Limitations, including numbers of non-responses,
can be improved in further studies in order to increase
conﬁdence in study outcomes. The results from this
pilot study have allowed the comparison of swabbing
methodologies for determining carriage of the targeted
bacterial species within the respiratory tract. The advan-
tages of self-swabbing are evident with higher responsive-
ness and lower costs than HCP swabbing. Further
assessment will determine whether our ﬁndings are
applicable to other geographical locations, over time
and to a wider array of bacterial species. Such assess-
ment would help to reﬁne methodologies, which will be
key to obtaining a precise understanding of bacterial car-
riage in the respiratory tract.
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